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IPD14:
CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY IMPROVES STAGE
1 AND STAGE 2 SLEEP NOCTURIA IN INDIVIDUALS WITH OBSTRUCTIVE
SLEEP APNEA
Eric Chieh-Lung Chou 1,4, Shinn-Jye Liang 2,3, Po-Fan Hsieh 1,4, Chao-Hsiang
Chang 1,4, His-Chin Wu 1,4. 1Department of Urology, China Medical
University Hospital, Taiwan; 2 Sleep Center, Departments of Internal
Medicine, China Medical University Hospital, Taiwan; 3Department of
Internal Medicine, China Medical University, Taiwan; 4Department of
Urology, China Medical University, Taiwan
Purpose: Nocturia is common in patients with obstructive sleep apnea
(OSA). The data on nocturia and the sleep architecture for patients un-
dergoing continuous positive airway pressure (CPAP) therapy are scarce.
This study evaluates the efﬁcacy of treatment and the change in nocturia
prevalence under the CPAP therapy in patients with OSA.
Materials and Methods: This prospective clinical study was conducted
from February 2012 to January 2013. A patient was deﬁned as having
nocturia if it occurred twice or more per night and lasted over 3 months.
The diagnosis of OSAwas established by a standard full night in-laboratory
polysomnography (PSG). The voiding diaries were recorded. Eligible noc-
turia patients with OSA were further arranged a CPAP titration.
Results: Twenty-ﬁve nocturia male patients were enrolled into our series,
and 23 met the diagnosis of OSA (92%). The CPAP showed an effective
reduction of apnea-hypopnea index (26.77 to 7.38, P < .0001), as well as
an increase in the mean oxygen saturation (81.87 to 88.00, P ¼ .0016). The
total nocturia urine volume was reduced after CPAP titration (P ¼ .0244).
Themajor impact of CPAP interventionwas on the stage 1 and stage 2 sleep
nocturia (P ¼ .001 and .04, respectively), but there was no difference for
REM nocturia (Table 1).
Conclusions: The urologists should be aware about the high prevalence of
OSA in nocturia patients. CPAP therapy effectively reduces stage 1 and
stage 2 sleep nocturia in OSA patients.
IPD16:
DEVELOPMENT OF A MODEL FOR DIAGNOSIS OF SUSPECTED
UROLITHIASIS SPECIFIC TO TAIWAN AND JAPAN
Hiroki Fukuhara, Hiroshi Kakizaki, Hisashi Kaneko, Takuya
Yamanobe, Shouko Nakayama, Shigemitsu Horie. Department of Urology,
Nihonkai General Hospital, Sakata, Japan
Purpose: To develop a safe and accurate diagnostic model for suspected
urolithiasis with seasonal variation, which is of special concern in Taiwan
and Japan.
Materials and Methods: We retrospectively reviewed the medical records
of all patients who visited our emergency room (ER) from April 1, 2007 to
October 31, 2014, with complaints of back, ﬂank, or lower abdominal pain.
A total of 80442 patients visited the ER during this period. In this popu-
lation, we selected 446 patients who received a deﬁnitive diagnosis based
on radiological images (328 had ureteral stones and 118 another disease),
and who did not have the following exclusion criteria: lack of any back,
ﬂank, or lower abdominal pain; congenital hydronephrosis; abnormal vital
signs (subjective or objective fever, or hypotension); positive leukocytes on
urine dipstick or qualitative urinalysis; known active malignancy; known
renal disease (creatinine > 1.5 mg/dl); insufﬁcient examination (lack of
urinalysis or lack of evaluation for hydronephrosis); and previous urologic
procedures, including lithotripsy or ureteral stenting. Urolithiasis-related
predictors derived with a multivariate logistic regression model were
converted into integer points, and the total of the points was used for
stratifying patients into groups with low, intermediate, and high risk for
urolithiasis.Results: Urolithiasis was associated with the hot season (July to
September), male gender, nausea or vomiting, prior history of urolithiasis,
duration of pain, microscopic hematuria, and hydronephrosis, yielding a
score of 0-13. Patients were stratiﬁed into the low (0-5), intermediate (6),
and high risk (7-13) groups. The prevalence of ureteral stones was 14.8%,
88.9%, and 98.6% in the low, intermediate, and high-risk groups, respec-
tively. Acute aortic dissection in the high risk group and abdominal aortic
aneurysm in the intermediate risk group were the most important dif-
ferential diagnoses for urolithiasis.
Conclusion: Score stratiﬁcation, and ruling out acute aortic dissection and
abdominal aortic aneurysm, are essential components in developing a safe
and accurate diagnostic model for suspected urolithiasis.
IPD17:
THE TREATMENT MODALITIES OF URETERAL STONES: A COMPARISON
OF COST
Justin Ji-Yuen Siu, Wen-Chi Chen. Department of Urology, China Medical
University Hospital, Taichung, Taiwan; School of Medicine, China Medical
University, Taichung, Taiwan
Purpose: Various studies have compared the cost-effectiveness between
extracorporeal shock-wave lithotripsy (ESWL) and ureteroscopic litho-
tripsy (URSL) in the treatment of ureteral stones. This study aims to
investigate the cost-effectiveness between ESWL and URSL on a national
level in Taiwan.
Materials andMethods: The National Health Insurance Research Database
(NHIRD) of Taiwan is a derivative of the National Health Insurance Program
of Taiwan that covers more than 99% of the population. The Longitudinal
Health Insurance Database 2000 (LHID2000) contains the claims ﬁled by
200,000 randomized individual patients from the NHIRD. 28,513 cases of
ureteral stone have been identiﬁed. We compared the total costs between
patients who underwent different lithotripsy modalities within six weeks
of diagnosis, in order to include the post-intervention costs.
Results: The total number of patients who received ESWL or invasive
intervention within six weeks of initial diagnosis was 9,155 (32.1%). The
mean medical cost was NTD 40,408 during the ﬁrst six weeks after diag-
nosis when ESWL was used as the primary treatment modality, while in
the case of URSL, the mean medical cost was NTD 38,224 (p < 0.05). The
presence of comorbidities was also related to a statistically signiﬁcant in-
crease in costs during the six weeks after initial diagnosis of ureteral stone.
Conclusion: When ESWL was used as a primary treatment modality for an
episode of ureteral stone, the cost of the entire course of treatment exceeds
URSL signiﬁcantly. This may assist health care providers to decide whether
ESWL or URSL is more suitable for a particular patient with ureteral stone
requiring intervention.
The paper can be assigned, per authors’ agreement, to ☑oral presentation
and/or poster presentation (please tick either or both boxes). Those papers
that are not ticked will be considered intended for both.
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NEW OPERATIVE METHOD USING GREEN LIGHT LEASER -GLEP (GREEN
LIGHT LEASER ENUCLEATION OF PROSTATE)-
Keisuke Saito, Takahiro Noguti, Takesi Ashizawa, Masayuki Kojya, Akira
Horiuti, Akira Hirano, Hisamitu Ide, Satoru Mutou, Raizou
Yamaguti. Teikyo University, Department of Urology, Japan
Purpose: In Teikyo University urology, we start HoLEP (Holmium YAG
Laser Enucleation of Prostate) in 2006 as transurethral prostatic enucle-
ation and experience about 400 examples cases. More, We introduce PVP
(Photo-Selective Vaporization of the Prostate) as transurethral prostatic
perspiration technique from 2012.
MaterialsandMethods:PVP is thesafeoperativemethodwhichwassuperior
in theperspirationefﬁciencyandhemostasispower.However, for a treatment
for large prostate, it is lined output limes of laser probe and experience and
technologyof apracticedhand.Thereforewereport theoperativemethod this
timebecausewe experiencedGLEP (Green light laser enucleationof prostate)
which is transurethral prostatic enucleation using PVP device. We call the
operative method GLEP (Green light leaser enucleation of prostate). Conﬁg-
uration of ﬁber has a large difference of operativemethod in GLEP andHoLEP.
